Tumour expression of PDL1, as determined by the combined positive score (CPS; the number of PDL1 staining cells divided by the total number of viable tumour cells, multiplied by 100) has been used to select and stratify patients on ICI trials (157). The gene discussed is CD274; the disease is neoplasm.